-
Tranilast (INN,
brand name Rizaben) is an
antiallergic drug. It was
developed by
Kissei Pharmaceuticals and was
approved in 1982 for use in ****an and...
-
Medical therapies include topical atropine,
topical retinoids, and oral
tranilast. The most
common adverse effects include redness, skin discoloration,...
-
unresectable plexiform neurofibroma and low-grade astrocytomas. In vitro,
tranilast,
inhibits growth of
neurofibroma cells. Gene
therapy for the neurofibromin...
- "Uncontrollable
prurigo nodularis effectively treated by
roxithromycin and
tranilast".
Journal of
Drugs in Dermatology. 5 (4): 363–365. PMID 16673805. Briatico...
- fibers. Oral retinoids, such as tretinoin, and
antifibrotic agents like
tranilast have been
tested for pseudo-ainhum.
Impending am****tion in Vohwinkel...
-
Linzagolix Mitiglinide (Glufast)
Remogliflozin etabonate Silodosin (Urief)
Tranilast (Rizaben) In
March 2020,
Kissei and CG Oncology, Inc.
announced an exclusive...
-
their ability to
prevent TGF-beta-stimulated
production of collagen.
Tranilast "Asengeprast
Ligand page". IUPHAR/BPS
Guide to PHARMACOLOGY. "Certa Therapeutics...
-
related 4-quinazolinone-based
pharmaceutical drugs, including:
Tioperidone Tranilast Pelanserin Diproqualone Antrafenine SJ-733
Nicafenine Molinazone Cloperidone...
-
Trandate trandolapril (INN)
trandolaprilat (INN)
tranexamic acid (INN)
tranilast (INN)
Tranmep Trans-Ver-Sal
transcainide (INN)
Transderm scop Transderm-Nitro...
- Blanco-Rivero J (2013). "Opposite
effect of mast cell
stabilizers ketotifen and
tranilast on the
vasoconstrictor response to
electrical field stimulation in rat...
